7.     Cordero A, Alegría E, León M. Prevalencia de síndrome metabólico. Rev Esp Cardiol. 2006; 5: 11 – 15

8.     Cordero Fort A, Alegría E, Montserrat León et al. Prevalencia de síndrome metabólico y asociación con la cardiopatía isquémica en pacientes cardiológicos ambulatorios. Rev Clin Esp. 2006; 206 (6): 259-265. 

9.     Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002; 287:356-9.

10.     Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl A. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health. 2007; 7:220.

11.     Erem C, Hacihasanoglu A, Deger O, Topbaş M, Hosver I, Ersoz HO, Can G. Prevalence of metabolic síndrome and associated risk factors among Turkish adults: Trabzon Mets Study. Endocrine. 2008; 33 (1): 9 – 20.

12.     Brown TD, Vaidya D, Rogers WJ, Waters DD, Howard BV, Tardif JC, Bittner V. Does the prevalence of the Metabolic Syndrome in women with coronary artery disease differ by the ATP III and IDF criteria ? Journal of Women's Health 2008; 17 (5): 841 – 47.

13.     Lombo B, Villalobos C, Tique C, Satizábal C, Franco CA. Prevalencia del síndrome metabólico entre los pacientes que asisten al servicio clínica de hipertensión de la Fundación Santa Fe de Bogotá. Rev. Colomb. Cardiol. 2006; 12 (7): 472-478.

14.     Gimeno Orna JA, Boned Juliani B, Lou Arnal LM. Prevalencia de síndrome metabólico en pacientes con diabetes tipo 2. An. Med. Interna (Madrid). [periódico en la Internet]. 2004 Jun [citado 2008 Nov 30]; 21(6): 59-61. Disponible en: http:// scielo. isciii. es/ scielo. php?scrip t=sci_ a rttext&p id=S021 2-719 9200 4000 60001 5&lng =es& nrm=iso.

15.     Schettini C, Schwedt E, Moreira V, Mogdasy C, Chávez AEL, Bianchi M et al. Prevalencia del síndrome metabólico en una población adulta. Rev Urug Cardiol. 2004; 9 (1):19-28.

16.     Pérez CM, Guzmán M, Ortiz AP, Estrella M, Valle Y, Pérez N et al. Prevalence of the metabolic syndrome in San Juan, Puerto Rico. Ethn Dis. 2008; 18(4):434-41.

17.     Hurtado H, Fernando N. Características Angiográficas de la Enfermedad de las Arterias Coronarias en pacientes con Síndrome Metabólico en el Hospital Central FAP de 1999 a 2002. Trabajo de investigación (Especialista en Cardiología)-- Universidad Nacional Mayor de San Marcos. Facultad de Medicina Humana. Unidad de Post-Grado, 2003.

18.     Hitsumoto T, Takahashi M, Iizuka T, Shirai K. Relationship between metabolic syndrome and early stage coronary atherosclerosis. J Atheroscler Thromb. 2007; 14 (6): 294 - 302.

19.     Marroquin OC, Kip KE, Kelley DE, Johnson BD, Shaw LJ, Bairey Merz CN, et al. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation. Circulation. 2004; 109 (6): 714-21.

20.   Solymoss BC, Bourassa MG, Lespérance J, Levesque S, Marcil M, Varga S, Campeau L et al. Incidence and clinical characteristics of the metabolic syndrome in patients with coronary artery disease. Coron Artery Dis. 2003; 14 (3): 207-12.

21.   Garin MCB, Kalix B, Morabia A, James R.W. et al. Small, Dense Lipoprotein Particles and Reduced Paraoxonase-1 in Patients with the Metabolic Syndrome. J Clin Endocrinol Metab. 2005; 90 (4): 2264–2269.

22.   Kasai T, Miyauchi K, Kubota N, Tamura H, Kojima T, Yokoyama K et al. The relationship between the metabolic syndrome defined by various criteria and the extent of coronary artery disease. Atherosclerosis. 2008; 197(2): 944-50.

23.   Yavuz B, Kabakci G, Aksoy H, Tulumen E, Deveci OS, Aytemir K et al. Determining the relationship between metabolic syndrome score and angiographic severity of coronary artery disease. Int J Clin Pract. 2008; 62 (5): 717-22.

24.   Sadeghi M, Garak-Yaraghi M, Saneie H, Rozati G, Roohafza H, Talaei M. Relationship between the Metabolic Syndrome and coronary artery disease in patients with stable angina. ARYA Journal. 2006; 2(1): 10-14

25.   Eberly LE, Prineas R, Cohen JD, Vazquez G, Zhi X, Neaton JD et al. Metabolic Syndrome. Risk factor distribution and 18-year mortality in the Multiple Risk Factor Intervention Trial. Diabetes Care. 2006; 29:123-130.

26.   Solymoss BC, Bourassa MG, Campeau L, Sniderman A, Marcil M, Lespérance J et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol 2004; 93 (2): 159-64.

27.   Sarau CA et al. Metabolic syndrome in patients with coronary artery by – pass grafting and its vascular consequences. TMJ 2006; 56 (2 - 3): 154 – 56.

28.   Hillier TA, Rousseau A, Lange C, Lépinay P, Cailleau M, Novak M et al. Practical way to assess metabolic syndrome using a continuous score obtained from principal component analysis. The D.E.S.I.R. cohort. Diabetología. 2006; 49: 1528 – 35.

29.   Mishra TK, Das S, Patnaik UK, Routray SN, Behera M. Relationship of Metabolic Syndrome with Quantum of Coronary Artery Disease in Indian Patients with Chronic Stable Angina. Metabolic syndrome and related disorders. Metabolic Syndrome and related disorders. 2004; 2 (3):187 – 91.